Hyperthermic intraperitoneal chemotherapy hipec in. The majority of patients with ovarian cancer oc receive an initial diagnosis of advanced disease that has spread from the ovaries to. Hyperthermic intraperitoneal chemotherapy hipec in ovarian cancer. Hipec has already been shown effective in recurrent ovarian cancer. Hyperthermic intraperitoneal chemotherapy hipec in conjunction with cytoreductive surgery crs holds promise as an adjunctive treatment strategy in malignancies affecting the peritoneal surface. Treatment of newly diagnosed advancedstage ovarian cancer typically involves cytoreductive surgery and systemic chemotherapy. Statement by the kommission ovar of the ago study group on the use of hipec hyperthermic intraperitoneal chemotherapy to treat primary and recurrent ovarian cancer. Ovarian cancer is the second most frequent malignant tumor of the female genital tract and the. Intraoperative hyperthermic intraperitoneal chemotherapy in. We investigated the effect of intraperitoneal hyperthermic perfusion chemotherapy as consolidation therapy in stage iiibiiic ovarian cancer, following cytoreductive surgery and systemic chemotherapy cisplatincyclophosphamidesix cycles.
Marys hospital between january 1994 and january 2000. Also known as hot chemotherapy, hipec is performed after the surgeon removes tumors or lesions from the abdominal area. Importance hyperthermic intraperitoneal chemotherapy hipec and cytoreductive surgery have been shown to benefit selected patients with peritoneal carcinomatosis. Pdf background treatment of newly diagnosed advancedstage ovarian cancer typically involves cytoreductive surgery and systemic. Hyperthermic intraoperative peritoneal chemotherapy hipec is also done for other cancers that have spread to the peritoneal surfaces of the abdomen after cytoreduction debulking surgery is completed, such as ovarian, colon, gastric and pancreatic cancers. This is referred to as early postoperative intraperitoneal chemotherapy epic. Hyperthermic intraperitoneal chemotherapy hipec appendix. We conducted a trial to investigate whether the addition of hyperthermic intraperitoneal chemotherapy hipec to in terval cytoreductive surgery would improve outcomes among patients who were re.
Hipec cooperative program md anderson cancer center. When performed in conjunction with cytoreductive surgery crs, intraoperative hyperthermic intraperitoneal chemotherapy hipec. Hyperthermic intraoperative peritoneal chemotherapy hipec is also done for other cancers that have spread to the. Rationale for hyperthermic intraperitoneal chemotherapy hipec in ovarian cancer. For women who have stage iii ovarian cancer cancer that has not spread outside the abdomen and whose cancers were optimally debulked no tumors larger than 1 cm after surgery, intraperitoneal ip chemotherapy might be given in addition to systemic chemo paclitaxel given in a vein. Among patients with stage iii epithelial ovarian cancer, the addition of hipec to interval cytoreductive surgery resulted in longer recurrencefree survival and overall survival than surgery alone. Hyperthermic intraperitoneal chemotherapy for ovarian. Sonke, md, phd 2 patients with advanced epithelial ovarian cancer have a high incidence of peritoneal disease recurrence despite maximal efforts to. Death occurred in 50% of the hyperthermic intraperitoneal chemotherapy group vs 62% of the control group.
Hyperthermic intraperitoneal chemotherapy hipec in newly diagnosed advanced ovarian cancer. Our data indicate that cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is feasible and associated with a reasonable morbidity rate and mortality rate in. What is the role of hyperthermic intraperitoneal chemotherapy in the. Bc cancer agency improving services and patientcentered care for fraser valley. Intraoperative hyperthermic intraperitoneal chemotherapy hipec. Hyperthermic intraperitoneal chemotherapy hipec, also referred to as intraperitoneal hyperthermic chemotherapy iphc, has been proposed as an alternative for the treatment of cancers within the peritoneal cavity, including primary peritoneal mesothelioma and gastric cancer. Peritonectomy followed by hyperthermic intraperitoneal chemotherapy hipec is a combined treatment approach for peritoneal carcinomatosis that, up until 2017, was not commonly used for ovarian cancer in australia. In this procedure, warmed anti cancer drugs are infused and circulated in the peritoneal cavity abdomen for a short period of time. Hyperthermic intraperitoneal chemotherapy in advanced. For women who have stage iii ovarian cancer cancer that has not spread outside the abdomen and whose cancers were optimally debulked no tumors larger than 1 cm after surgery, intraperitoneal ip.
To evaluate the clinical effect of intraperitoneal hyperthermic chemotherapy iphc in ovarian cancer patients. Hyperthermic intraperitoneal chemotherapy hipec in newly. Intraperitoneal hyperthermic chemoperfusion hipec or iphc is a type of hyperthermia therapy used in combination with surgery in the treatment of advanced abdominal cancers. Hyperthermic intraperitoneal chemotherapy hipec is a single intraoperative approach that also targets the peritoneal surface. And there are also studies focus on treatment for it, such as parp inhibitors 23,24, hyperthermic intraperitoneal chemotherapy 25 and nanotherapy, but until now, survival rate of ovarian. When performed in conjunction with cytoreductive surgery crs, intraoperative hyperthermic intraperitoneal. Indications for hyperthermic intraperitoneal chemotherapy with.
Patients with advanced epithelial ovarian cancer have a high incidence of peritoneal disease recurrence despite maximal efforts to surgically. Jan 11, 2019 in the 1990s, cytoreductive surgery crs with hyperthermic intraperitoneal chemotherapy hipec emerged as a promising treatment for patients with peritoneal carcinomatosis from gastrointestinal and ovarian cancer without extraabdominal disease. A randomized phase 3 trial showed significant benefit in recurrence. Hyperthermic intraperitoneal chemotherapy with paclitaxel in advanced ovarian cancer hipecova the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Hyperthermia itself has cytotoxic effects and can potentiate antineoplastic. Mar, 2019 hipec hyperthermic intraperitoneal chemotherapy is the administration of heated chemotherapy meds into the peritoneum after surgery. Efficacy of hyperthermic intraperitoneal chemotherapy in. To the editor, we read with great interest the recently published article by van driel et al. However, the main mode of recurrence of ovarian cancer is pc and it often remains a locoregional disease for a long time, confined to the peritoneum and intraabdominal viscera. Hyperthermic intraperitoneal chemotherapy hipec is a treatment used. Safety and potential benefit of hyperthermic intraperitoneal chemotherapy hipec in peritoneal carcinomatosis from primary or recurrent ovarian cancer.
Hipec in recurrent ovarian cancer has been studied somewhat more extensively but largely in a retrospective manner with a variety of. Hyperthermic intraperitoneal chemotherapy hipec is a cancer treatment that involves filling the abdominal cavity with chemotherapy drugs that have been heated. We conducted a trial to investigate whether the addition of hyperthermic intraperitoneal chemotherapy hipec to in terval cytoreductive surgery. Gynecologic oncology group surgical procedures manual. Ovarian canceroc is one of the most lethal gynecologic cancers with 22,440 new cases and 14,080 deaths anticipated by 2017 in the united states. Early averagerisk colon cancer screening test temporarily. The prognosis impact of hyperthermic intraperitoneal. Intraperitoneal chemotherapy ip and hyperthermic intraperitoneal chemotherapy hipec outline. We investigated the effect of intraperitoneal hyperthermic perfusion chemotherapy as consolidation therapy in stage iiibiiic ovarian cancer, following cytoreductive surgery and systemic. Intraperitoneal hyperthermic chemotherapy in ovarian cancer. Hyperthermic intraperitoneal chemotherapy and cytoreductive surgery in the management of peritoneal carcinomatosis rahul rajeev, mbbs, and kiran k. Hyperthermic intraperitoneal chemotherapy the addition of hipec with cisplatin to cytoreductive surgery in stage iii ovarian cancer resulted in recurrencefree survival that was longer by 3. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer ki sung ryu,a jae hoon kim,b hyun sun ko,c jin woo kim,c woong shick ahn,c yong gyu park,d seung jo kim,e and joon mo leec.
Hyperthermic intraperitoneal chemotherapy hipec in conjunction with cytoreductive surgery crs holds promise as an adjunctive treatment strategy in malignancies affecting the peritoneal surface, effectively targeting remaining microscopic residual tumor. Pdf hyperthermic intraperitoneal chemotherapy in ovarian cancer. The role of hyperthermic intraperitoneal chemotherapy hipec in. Effects of intraperitoneal hyperthermic chemotherapy in. In ip chemotherapy, the drugs cisplatin and paclitaxel are. Apr 17, 2019 ovarian cancer oc is one of the most lethal gynecologic cancers with 22,440 new cases and 14,080 deaths anticipated by 2017 in the united states.
Surgery is the optimal treatment for earlystage ovarian cancer, and platinumbased chemotherapy followed by debulking surgery is the standard therapy for advanced ovarian cancer. How is hipec hyperthermic intraperitoneal chemotherapy used. The effect of age on the tolerability of intraperitoneal chemotherapy, complication rate, and survival in patients with ovarian cancer. Chemotherapy for ovarian cancer intraperitoneal chemotherapy. Complete cytoreduction may improve survival in highly selected patients low tumor volume and no organ metastases. Hyperthermic intraperitoneal chemotherapy hipec and cytoreductive surgery crs in ovarian cancer. No significant differences between the hipec and control groups were observed in the incidence of adverse events of any grade.
Jun 28, 2004 our data indicate that cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is feasible and associated with a reasonable morbidity rate and mortality rate in patients with peritoneal carcinomatosis and ovarian cancer. Bc scientists uncover new subtypes of ovarian cancer with new potential treatment strategies. In the setting of crs and hyperthermic intraperitoneal peroperative chemotherapy hipec, cisplatin has been used for intracavitary therapy of ovarian cancer in several phase ii studies37,38. The prognosis impact of hyperthermic intraperitoneal chemotherapy. The prognosis impact of hyperthermic intraperitoneal chemotherapy hipec plus cytoreductive surgery crs in advanced ovarian cancer. Hyperthermic intraperitoneal chemotherapy in advanced ovarian. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. Hyperthermic intraperitoneal chemotherapy in ovarian cancer article pdf available in new england journal of medicine 3783.
Hipec increases concentrations of chemotherapy directly within the peritoneal cavity compared with the intravenous route and reduces the. How is hipec hyperthermic intraperitoneal chemotherapy. We conducted a trial to investigate whether the addition of hyperthermic intraperitoneal chemotherapy hipec to interval cytoreductive surgery. Diseasefree survival, overall survival, and side effects were compared with a control group of patients who refused a secondlook surgery and. Hyperthermic intraperitoneal chemotherapy in ovarian cancer article pdf available in new england journal of medicine. In the 1990s, cytoreductive surgery crs with hyperthermic intraperitoneal chemotherapy hipec emerged as a promising treatment for patients with peritoneal carcinomatosis from. Mar 16, 2018 hyperthermic intraperitoneal chemotherapy hipec in newly diagnosed advanced ovarian cancer.
Intraoperative hyperthermic intraperitoneal chemotherapy. Peritonectomy followed by hyperthermic intraperitoneal chemotherapy hipec is a combined treatment approach for peritoneal carcinomatosis that, up until 2017, was not commonly used for ovarian cancer. A new trial shows for the first time that hipec improved outcomes for women with newly diagnosed advanced cancer too. Hyperthermic intraperitoneal chemotherapy and cytoreductive. Cytoreductive surgery and hyperthermic intraperitoneal. Hyperthermic intraperitoneal chemotherapy with paclitaxel in. When performed in conjunction with cytoreductive surgery crs, intraoperative hyperthermic intraperitoneal chemotherapy hipec is proven and medically necessary for treating the following conditions. Jan 18, 2018 hyperthermic intraperitoneal chemotherapy in ovarian cancer article pdf available in new england journal of medicine 3783. Pdf hyperthermic intraperitoneal chemotherapy in ovarian. Unique study compares cancer incidence and survival between first nations and nonfirst nations people in bc. Hyperthermic intraperitoneal chemotherapy hipec bc cancer.
Despite numerous recent advances in chemotherapy, the overall chance of chemotherapy being curative is still low, and the side effects are difficult for the. In this new context of hipec, crucial questions with cytoreductive surgery plus hipec in ovarian cancer are the modulation of systemic recurrence rate and site. The role of heated intraperitoneal chemotherapy hipec in ovarian cancer. Heated intraperitoneal chemotherapy in the management of. Funding and disclosures supported by the dutch cancer society nki 20064176. Dietrich 1, 1 division of gynecologic oncology, university of kentucky, lexington, ky 40502, usa. Pdf hyperthermic intraperitoneal chemotherapy hipec in. Hyperthermic intraperitoneal chemotherapy hipec in ovarian. Should hyperthermic intraperitoneal chemotherapy be the new. Hyperthermic intraperitoneal chemotherapy wikipedia. Pharmacology of cancer chemotherapy drugs for hyperthermic. Most ovarian cancers are either ovarian epithelial carcinomas cancer that begins in the cells on the surface of the ovary or malignant germ cell tumors cancer that begins in egg cells. In the intentiontotreat analysis, events of disease recurrence or death occurred in 110 of the 123 patients 89% who underwent cytoreductive surgery without hipec surgery group and in 99 of.
Hyperthermic intraperitoneal chemotherapy with paclitaxel. Hyperthermic intraperitoneal chemotherapy for ovarian cancer. For patients with newly diagnosed, primary stage iii epithelial ovarian, fallopian tube or primary peritoneal carcinoma, hipec with crs should. First explored in ovarian malignancies in the 1980s, hyperthermic intraperitoneal chemotherapy hipec in conjunction with cytoreductive surgery crs has become central in controlling peritoneal disease and improving survival outcomes in selected patients with peritoneal surface malignancies 1.
1326 1427 885 551 755 1391 1448 1436 485 985 1085 47 775 566 1278 770 189 640 29 1102 207 723 1061 643 983 1238 75 110 556 201 104 155 901 466 59 1127 199 908 1325